Immunomodulatory imide drugs (IMiDs), such as thalidomide and its analogues, are some of the most commonly utilized E3 ligase ligands for the development of proteolysis targeting chimeras (PROTACs).

A new study published in the journal Molecules highlights how microwave and ultrasound-assisted extraction methods can ...